U.S. market Closed. Opens in 11 hours 56 minutes

QNRX | Quoin Pharmaceuticals, Ltd. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/A-280.00K
Cost of Revenue103.44K103.64K104.11K104.77K227.06KN/A
Gross Profit-103.44K-103.64K-104.11K-104.77K-227.06K-280.00K
Operating Expenses9.25M9.26M6.06M1.67M1.56M16.22M
Selling, General & Admin6.05M6.58M4.50M1.43M1.51M7.97M
Research & Development3.20M2.67M1.56M244.16K45.65K8.26M
Other Operating ExpensesN/A417.31K-14.03M-378.33KN/AN/A
Operating Income-9.35M-8.85M-20.37M-2.05M-1.56M15.32M
Other Expenses / Income690.15K-532.80K-1.09M-47.02K1.55MN/A
Before Tax Income-8.66M-9.38M-21.46M-2.10M-1.56M15.32M
Income Tax Expenses8.66M-104.04K-12.94M-331.31K1.55MN/A
Net Income-8.66M-9.28M-8.52M-1.76M-1.56M15.32M
Interest ExpensesN/A714.08K1.09M47.02K412.29KN/A
Basic Shares Outstanding900.92K403.88K26.41K20.02K3.54KN/A
Diluted Shares Outstanding900.92K403.88K26.41K20.02K3.54KN/A
EBITDA-9.25M-8.74M-20.27M-1.94M-1.54M15.32M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%-5,470.36%
EBITN/A-8.67M-20.37M-2.05M402.27K15.32M
EBIT Margin0.00%0.00%0.00%0.00%0.00%-5,470.36%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙